Curis, Inc. (CRIS)
1.35
-0.02
(-1.46%)
USD |
NASDAQ |
Sep 04, 16:00
1.36
+0.01
(+0.74%)
After-Hours: 20:00
Curis Enterprise Value : -1.942M for Sept. 4, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 04, 2026 | -1.942M |
| September 03, 2026 | -1.903M |
| September 02, 2026 | -1.883M |
| September 01, 2026 | -1.805M |
| August 31, 2026 | -1.669M |
| August 28, 2026 | -1.669M |
| August 27, 2026 | -1.650M |
| August 26, 2026 | -1.572M |
| August 25, 2026 | -1.474M |
| August 24, 2026 | -1.494M |
| August 21, 2026 | -1.494M |
| August 20, 2026 | -1.435M |
| August 19, 2026 | -1.221M |
| August 18, 2026 | -1.260M |
| August 17, 2026 | -1.065M |
| August 14, 2026 | -1.065M |
| August 13, 2026 | -0.9284M |
| August 12, 2026 | -1.318M |
| August 11, 2026 | -0.0708M |
| August 10, 2026 | 2.560M |
| August 07, 2026 | 3.262M |
| August 06, 2026 | 4.022M |
| August 05, 2026 | 4.285M |
| August 04, 2026 | 4.626M |
| August 03, 2026 | 5.464M |
| Date | Value |
|---|---|
| July 31, 2026 | 5.211M |
| July 30, 2026 | 5.094M |
| July 29, 2026 | 5.133M |
| July 28, 2026 | 4.841M |
| July 27, 2026 | 4.568M |
| July 24, 2026 | 4.958M |
| July 23, 2026 | 4.529M |
| July 22, 2026 | 5.055M |
| July 21, 2026 | 4.685M |
| July 20, 2026 | 4.236M |
| July 17, 2026 | 4.451M |
| July 16, 2026 | 5.133M |
| July 15, 2026 | 4.646M |
| July 14, 2026 | 4.490M |
| July 13, 2026 | 4.685M |
| July 10, 2026 | 5.094M |
| July 09, 2026 | 5.094M |
| July 08, 2026 | 5.045M |
| July 07, 2026 | 5.737M |
| July 06, 2026 | 7.004M |
| July 02, 2026 | 8.938M |
| July 01, 2026 | 11.88M |
| June 30, 2026 | 15.78M |
| June 29, 2026 | 4.006M |
| June 26, 2026 | -0.8311M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 615.81M |
| Amgen, Inc. | 279.68B |
| Anika Therapeutics, Inc. | 265.34M |
| BioCryst Pharmaceuticals, Inc. | 3.026B |
| Imunon, Inc. | 8.353M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.581M |
| Total Expenses (Quarterly) | 8.581M |
| EPS Diluted (Quarterly) | -4.017 |
| Earnings Yield | -1.06K% |
| Normalized Earnings Yield | -2197.10 |